Company: ARWR
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001628280-25-024666
Chunk: 10

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part II, Item 2
Chunk 10
---
 were redacted by means of marking such portions with asterisks because the identified portions are (i) not material and (ii) treated as private or confidential by the Company.

33

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized. 

Dated: May 12, 2025

ARROWHEAD PHARMACEUTICALS, INC.By:/s/ Kenneth A. MyszkowskiKenneth A. MyszkowskiChief Financial Officer(Principal Financial Officer and Duly Authorized Officer)

34